Clinical trial of a first generation biconjugate Staphylococcus aureus vaccine

Trial Profile

Clinical trial of a first generation biconjugate Staphylococcus aureus vaccine

Planning
Phase of Trial: Phase I

Latest Information Update: 04 May 2010

At a glance

  • Drugs Staphylococcus aureus vaccine (Primary)
  • Indications Staphylococcal infections
  • Focus Adverse reactions; Pharmacodynamics
  • Most Recent Events

    • 04 May 2010 New trial record
    • 04 May 2010 The trial is expected to commence in late 2011, according to a GlycoVaxyn media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top